Insights from OCT Nordics 2024
The two-day conference at the Clarion Hotel & Congress offered a valuable opportunity for professionals in the pharma, biotech, medical device, clinical trial technology, and CRO sectors to network. It served as a platform to exchange ideas on operational innovations revolutionizing clinical trials.
The most popular subjects during the conference were decentralized clinical trials (DCTs) and the technologies transforming patient engagement. Attendees were engaged in conversations about how integrating these solutions not only reduces patient burden but also accelerates trials while maintaining high-quality data integrity. As part of the discussions, we asked David Hal Mollerup, Senior Director, Clinical Data Science at ALK, about the future role of machine learning and AI in clinical data management. He shared the following insight: "Machine learning will help us clean a lot of data in a semi-automatic manner, reducing the time we spend on data management and improving the timeliness of data readiness."
This perspective echoed broader conversations on AI in clinical analytics and innovations in protocol design, which resonated throughout the event. The popular subjects extended beyond the conference rooms and into the networking sessions, where discussions centered on streamlining trial processes, reducing patient burden, and incorporating advanced data management strategies. These insights enriched the dialogue among participants and served as a precursor to the evening networking event hosted by CRS and Viedoc.
Following an engaging first day, Viedoc and CRS, hosted a much-appreciated dinner at the Skybar at Scandic Strandpark, offering breathtaking views of the Copenhagen skyline. With over 55 key players from the conference in attendance, the night carried on the day’s vibrant energy—filled with laughter, great food, and in-depth conversations that carried on long into the evening. Antonio Mastroianni from Viedoc remarked:
The casual setting fostered deep and genuine conversations among participants from various sectors of the clinical trial field. This environment encouraged thoughtful reflection on managing clinical trial data and making decisions based on evidence. We're grateful to everyone who took the time to join us. Your presence and dialogue made the night special.
For over 40 years, CRS has been committed to advancing drug development and improving patient lives. As a leading full-service Contract Research Organization (CRO), they specialize in early-phase clinical research, leveraging their expertise from First-in-Human studies to Proof-of-Concept trials, supported by their advanced research units in Germany. They serve a diverse range of clients across pharmaceuticals, biotech, and more, making them a trusted partner in navigating the drug development journey.
CRS and Viedoc bring over 60 years of combined expertise in clinical research—CRS through early-phase drug development and Viedoc with innovative software to streamline trials. This dinner was a celebration of our shared commitment to advancing clinical research and delivering life-changing treatments. The evening's success was a testament to the dedication of both teams, ensuring a memorable experience for all attendees. To see where we'll be next and join us at upcoming events, check out our events page for the remainder of the year.
"Viedoc makes building a study easy and fun. It doesn't require extensive coding knowledge; it's quick to get in and start working."